Gentherapie in der Ophthalmologie: Stand der Forschung

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Klinische Monatsblätter für Augenheilkunde

• Publication date

  2012-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1055/s-0032-1312914PMID 22752982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new tool for the transfection of corneal endothelial cells: calcium phosphate nanoparticles.

  2012cited by this paper
• Temperature sensitive contact lenses for triggered ophthalmic drug delivery.

  2012cited by this paper
• Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor.

  2012cited by this paper
• The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation.

  2011cited by this paper
• Systemic Adeno-Associated Virus-Mediated Gene Therapy Preserves Retinal Ganglion Cells and Visual Function in DBA/2J Glaucomatous Mice

  2011cited by this paper
• Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo

  2011cited by this paper
• Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage

  2011cited by this paper
• Gene Transfer for Neovascular Age-Related Macular Degeneration

  2011cited by this paper
• Corneal Endothelial Cells Are Protected from Apoptosis by Gene Therapy

  2011cited by this paper
• Nanotechnology and Nanotoxicology in Retinopathy

  2011cited by this paper
• Decorin biology, expression, function and therapy in the cornea.

  2011cited by this paper
• Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

  2011cited by this paper
• Nanoparticles for retinal gene therapy.

  2010cited by this paper
• Silver nano - a trove for retinal therapies.

  2010cited by this paper
• Gene delivery in the equine cornea: a novel therapeutic strategy.

  2010cited by this paper
• Gene delivery to the retina: focus on non-viral approaches.

  2009cited by this paper
• The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection.

  2009cited by this paper
• Persistent expression of PEDF in the eye using high-capacity adenovectors.

  2008cited by this paper
• Inorganic nanoparticles as carriers of nucleic acids into cells.

  2008cited by this paper
• Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

  2008cited by this paper
• Effect of gene therapy on visual function in Leber's congenital amaurosis.

  2008cited by this paper
• Nanoparticle applications in ocular gene therapy.

  2008cited by this paper
• Gene therapy for ocular neovascularization.

  2007cited by this paper
• Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing

  2007cited by this paper
• Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

  2006cited by this paper
• Gene therapy progress and prospects: the eye

  2006cited by this paper
• Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.

  2006cited by this paper
• Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

  2005cited by this paper
• Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success

  2005cited by this paper
• Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis

  2004cited by this paper
• Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

  2004cited by this paper
• Lentiviral Vector-Mediated Delivery of Short Hairpin RNA Results in Persistent Knockdown of Gene Expression in Mouse Brain

  2003cited by this paper
• Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

  2003cited by this paper
• Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.

  2003cited by this paper
• Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

  2002cited by this paper
• Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

  2002cited by this paper
• AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

  2002cited by this paper
• Gene targeting to the retina.

  2001cited by this paper
• Gene therapy restores vision in a canine model of childhood blindness

  2001cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Endothelkritische Prozeduren während der Herstellung und Transplantation posteriorer lamellärer Hornhauttransplantate

  2017cites this paper